AAAAAA
Results:
1-23
|
Results: 23
Authors:
Blackwell, RE
Hammond, KR
Citation: Re. Blackwell et Kr. Hammond, Hormonal control of normal breast morphology and function, CONT ENDOC, 11, 1999, pp. 3-20
Authors:
Plu-Bureau, G
Touraine, P
Marvais-Jarvis, P
Citation: G. Plu-bureau et al., Interactions between estradiol and progesterone in normal breast - Implications for mammary carcinogenesis, CONT ENDOC, 11, 1999, pp. 21-37
Authors:
Richert, MM
Wood, TL
Citation: Mm. Richert et Tl. Wood, Expression and regulation of insulin-like growth factors and their bindingproteins in the normal breast, CONT ENDOC, 11, 1999, pp. 39-52
Authors:
Feigelson, HS
Henderson, BE
Citation: Hs. Feigelson et Be. Henderson, Estrogens and breast cancer - An epidemiologic perspective, CONT ENDOC, 11, 1999, pp. 55-67
Authors:
James, VHT
Citation: Vht. James, Androgens, estrogens, and breast cancer risk, CONT ENDOC, 11, 1999, pp. 69-77
Authors:
Tekmal, RR
Santen, RJ
Citation: Rr. Tekmal et Rj. Santen, Local estrogen production - Is aromatase an oncogene?, CONT ENDOC, 11, 1999, pp. 79-92
Authors:
Veronese, ML
Bullrich, F
Croce, CM
Citation: Ml. Veronese et al., Oncogenes and mammary carcinogenesis, CONT ENDOC, 11, 1999, pp. 93-108
Authors:
Dogliotti, L
Caraci, P
Citation: L. Dogliotti et P. Caraci, Categorization of breast cyst fluid and breast cancer risk, CONT ENDOC, 11, 1999, pp. 109-116
Authors:
Callahan, R
Citation: R. Callahan, The role of tumor suppressor genes in breast cancer progression, CONT ENDOC, 11, 1999, pp. 119-132
Authors:
Pietras, RJ
Pegram, MD
Citation: Rj. Pietras et Md. Pegram, Oncogene activation and breast cancer progression, CONT ENDOC, 11, 1999, pp. 133-153
Authors:
Cullen, KJ
Kaup, SS
Rasmussen, AA
Citation: Kj. Cullen et al., Interactions between stroma and epithelium in breast cancer - Implicationsfor tumor genesis, growth, and progression, CONT ENDOC, 11, 1999, pp. 155-168
Authors:
Kern, FG
Citation: Fg. Kern, Role of angiogenesis in the transition to hormone independence and acquisition of the metastatic phenotype, CONT ENDOC, 11, 1999, pp. 169-186
Authors:
Lee, AV
Yee, D
Citation: Av. Lee et D. Yee, Role of the IGF system in breast cancer proliferation and progression, CONT ENDOC, 11, 1999, pp. 187-203
Authors:
Klijn, JGM
Berns, EMJJ
Foekens, JA
Citation: Jgm. Klijn et al., Prognostic and predictive factors in breast cancer, CONT ENDOC, 11, 1999, pp. 205-220
Authors:
Manni, A
Citation: A. Manni, Role of the polyamine pathway in the natural history of breast cancer, CONT ENDOC, 11, 1999, pp. 221-230
Authors:
Harvey, HA
Citation: Ha. Harvey, Aromatase inhibitors in breast carcinoma, CONT ENDOC, 11, 1999, pp. 233-243
Authors:
Guiochon-Mantel, A
Milgrom, E
Citation: A. Guiochon-mantel et E. Milgrom, Role of progestins and progesterone receptors in breast cancer biology, CONT ENDOC, 11, 1999, pp. 245-259
Authors:
Vonderhaar, BK
Citation: Bk. Vonderhaar, Prolactin and its receptors in human breast cancer, CONT ENDOC, 11, 1999, pp. 261-279
Authors:
Gradishar, WJ
Jordan, VC
Citation: Wj. Gradishar et Vc. Jordan, Pharmacology and use of antiestrogens in treatment and chemoprevention of breast cancer, CONT ENDOC, 11, 1999, pp. 283-311
Authors:
Mainwaring, PN
Dowsett, M
Citation: Pn. Mainwaring et M. Dowsett, LHRH superagonists and antagonists in the treatment of breast cancer, CONT ENDOC, 11, 1999, pp. 313-328
Authors:
Jensen, RA
Citation: Ra. Jensen, Benign breast lesions - Pathologic classification and risk potential, CONT ENDOC, 11, 1999, pp. 331-346
Authors:
Dogliotti, L
Caraci, P
Citation: L. Dogliotti et P. Caraci, Hormonal treatment of fibrocystic disease, CONT ENDOC, 11, 1999, pp. 347-357
Authors:
Kleinberg, DL
Citation: Dl. Kleinberg, Gynecomastia and galactorrhea., CONT ENDOC, 11, 1999, pp. 359-382
Risultati:
1-23
|